Detalhe da pesquisa
1.
Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial.
Breast Cancer Res Treat
; 181(1): 61-68, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32200486
2.
Increased mean corpuscular volume of red blood cells in patients treated with capecitabine for advanced breast and colon cancer.
Chemotherapy
; 59(5): 369-72, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24821441
3.
Acupuncture As an Integrative Approach for the Treatment of Hot Flashes in Women With Breast Cancer: A Prospective Multicenter Randomized Controlled Trial (AcCliMaT).
J Clin Oncol
; 34(15): 1795-802, 2016 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27022113
4.
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial.
J Clin Oncol
; 29(27): 3628-35, 2011 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21844495
5.
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial.
Cancer Chemother Pharmacol
; 64(5): 1021-7, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19266200
6.
Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer.
J Clin Oncol
; 26(6): 890-6, 2008 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18281662
7.
Single-agent gemcitabine in previously untreated elderly patients with advanced bladder carcinoma: response to treatment and correlation with the comprehensive geriatric assessment.
Oncology
; 67(1): 27-32, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15459492